<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
______________
Date of Report (Date of earliest event reported): October 9, 2000
CuraGen Corporation
(Exact name of registrant as specified in its charter)
Delaware 0-23223 06-1331400
--------------- ----------- -------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
555 Long Wharf Drive, 11th Floor
New Haven, Connecticut 06511
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (203) 401-3330
----------------------
<PAGE>
ITEM 5. OTHER EVENTS.
On October 9, 2000, the Registrant publicly disseminated a press release
announcing that it has filed a Form S-3 shelf registration statement for the
sale of up to $500 million of various types of securities. The information
contained in such press release is incorporated herein by reference and filed as
Exhibit 99.1 hereto. In addition, on October 9, 2000, the Registrant publicly
disseminated a press release announcing that it has licensed five drug targets
to Biogen, Inc., marking the completion of the research portion of their
discovery collaboration. The information contained in such press release is
incorporated herein by reference and filed as Exhibit 99.2 hereto.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
99.1 The Registrant's Press Release dated October 9, 2000.
99.2 The Registrant's Press Release dated October 9, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CURAGEN CORPORATION
(Registrant)
Date: October 9, 2000 By: /s/ David Wurzer
----------------------------
Executive Vice President and
Chief Financial Officer
<PAGE>
EXHIBIT INDEX
Exhibit Sequential
Number Description Page Number
------- ----------- -----------
99.1 The Registrant's Press Release 5
dated October 9, 2000.
99.2 The Registrant's Press Release 6
dated October 9, 2000.
